"Our goal in the LATIFY trial was to reinvigorate the immune response of patients with lung cancer whose tumours stopped ...
Yet, many medical affairs teams remain bound to traditional workflows. Linear processes and siloed functions are struggling ...
US companies Amgen, Bristol Myers Squibb, Gilead Sciences, and Merck/MSD have signed up to reduce the prices of medicines for ...
In 2025, women’s health moved from recognition to getting foundations in place, with new funding vehicles, national ...
Combined, the two drugs made revenues of nearly $600 million in the last four quarters, while BioMarin has forecast that its ...
While everyone agrees on the ethical imperative to reduce animal use, the challenge of widespread readiness will depend on partnership, proof, and continued development activities. Public perception ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback